Literature DB >> 12441033

Helicobacter pylori-Associated Diseases.

Michael K Sanders1, David A Peura.   

Abstract

Since the initial report 20 years ago by Marshall and Warren of an unidentified curved bacillus located on the gastric epithelium of patients with chronic active gastritis, the discovery of Helicobacter pylori and its association with a number of gastrointestinal diseases has revolutionized the field of gastroenterology. Although the association of H. pylori infection with peptic ulcer disease, chronic gastritis, mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma has been well documented over the past two decades, other areas remain less clear, including the role of H. pylori in gastropathy associated with nonsteroidal anti-inflammatory drugs, gastroesophageal reflux disease, and both uninvestigated and nonulcer dyspepsia. Although these areas still remain somewhat controversial, recent reports further clarify the role of H. pylori in these conditions. A review of the recent literature regarding H. pylori-associated diseases is presented along with recommendations for diagnosis and treatment of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441033     DOI: 10.1007/s11894-002-0019-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  47 in total

1.  Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

Authors:  Francis K L Chan; K F To; Justin C Y Wu; M Y Yung; W K Leung; Timothy Kwok; Y Hui; Henry L Y Chan; Cynthia S Y Chan; Elsie Hui; Jean Woo; Joseph J Y Sung
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

2.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 3.  Review article: gastro-oesophageal reflux disease and Helicobacter pylori infection.

Authors:  N B Vakil
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

Review 4.  Review article: diagnosis of Helicobacter pylori infection.

Authors:  D Vaira; L Gatta; C Ricci; M Miglioli
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

5.  The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.

Authors:  G Ott; T Katzenberger; A Greiner; J Kalla; A Rosenwald; U Heinrich; M M Ott; H K Müller-Hermelink
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

7.  T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Authors:  Hongxiang Liu; Hongtao Ye; Agnes Ruskone-Fourmestraux; Daphne De Jong; Stefano Pileri; Christian Thiede; Anne Lavergne; Henk Boot; Giancarlo Caletti; Thomas Wündisch; Thierry Molina; Babs G Taal; Sabattini Elena; Togliani Thomas; Pier Luigi Zinzani; Andreas Neubauer; Manfred Stolte; Rifat A Hamoudi; Ahmet Dogan; Peter G Isaacson; Ming-Qing Du
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 8.  Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.

Authors:  A Morgner; C Thiede; E Bayerdörffer; B Alpen; T Wündisch; A Neubauer; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2001-12

9.  Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.

Authors:  P Moayyedi; C Bardhan; L Young; M F Dixon; L Brown; A T Axon
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

Review 10.  Recent developments in Helicobacter pylori vaccination.

Authors:  J G Kusters
Journal:  Scand J Gastroenterol Suppl       Date:  2001
View more
  21 in total

1.  CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease.

Authors:  Bingsheng Huang; Ying Chen; Qiang Xie; Guixiong Lin; Yuyan Wu; Yanlin Feng; Jingcao Li; Yufeng Zhuo; Peng Zhang
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.199

2.  Detection of H. pylori antibody profile in serum by protein array.

Authors:  Feng-Chan Han; Xu-Jun Li; Hong Jiang; Li-Peng Qin; Ding Li; Yan-Hai Guo; Zhi-Guang Liu; Li Zhang; Xiao-Jun Yan
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

3.  Symptom improvement after helicobacter pylori eradication in patients with functional dyspepsia-A multicenter, randomized, prospective cohort study.

Authors:  Sanping Xu; Xueming Wan; Xiaolan Zheng; Yali Zhou; Zhiqiang Song; Minghu Cheng; Yiqi Du; Xiaohua Hou
Journal:  Int J Clin Exp Med       Date:  2013-09-25

4.  No Association Found Between Midlife Seropositivity for Infection and Subsequent Cognitive Decline: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Authors:  Kristen M George; Aaron R Folsom; Faye L Norby; Pamela L Lutsey
Journal:  J Geriatr Psychiatry Neurol       Date:  2019-06-16       Impact factor: 2.680

Review 5.  The spectrum of gastric disease associated with Helicobacter pylori and other infectious gastritides.

Authors:  Jeannette Guarner
Journal:  Curr Gastroenterol Rep       Date:  2004-12

6.  Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori.

Authors:  Feng-Chan Han; Han-Chong Ng; Bow Ho
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Advocacy, promotion and e-learning: Supercourse for zoonosis.

Authors:  Gino C Matibag; Manabu Igarashi; Ron E La Porte; Hiko Tamashiro
Journal:  Environ Health Prev Med       Date:  2005-09       Impact factor: 3.674

8.  Identification of H. pylori strain specific DNA sequences between two clinical isolates from NUD and gastric ulcer by SSH.

Authors:  Feng-Chan Han; Min Gong; Han-Chong Ng; Bow Ho
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Expression of CagL from Helicobacter pylori and Preliminary Study of its Biological Function.

Authors:  Hua Wang; Shiteng Huang; Jianzhong Zhao; Jun Han; Xianwei Guan; Shihe Shao
Journal:  Indian J Microbiol       Date:  2012-12-15       Impact factor: 2.461

10.  Prominent role of gamma-glutamyl-transpeptidase on the growth of Helicobacter pylori.

Authors:  Min Gong; Bow Ho
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.